ParaX®: The Science Behind our Breakthroughs

Bringing precision to anti-parasitic drug discovery by combining multitude of experimental data.

Our Approach

Microtubules are a proven drug target, with microtubule-targeting agents (MTAs) successfully used to treat diseases like cancer. These dynamic filaments, essential for cell structure and division, also play a critical role in eukaryotic pathogens. Over time, parasites have evolved distinct microtubule modifications, setting them apart from their hosts. This unique divergence presents a powerful opportunity for targeted, host-safe therapies. By applying a proven strategy to a new frontier, we are pioneering breakthrough treatments that disrupt parasite microtubules with precision—without harming healthy cells.

OUR SOLUTION ParaX®

Our Precision Lead Generator

With our ParaX® Platform, we have perfected the technology to exploit subtle sequence differences between tubulins from parasite pathogens and hosts to enable specific inhibitor design by precision atomic scale drug engineering. We call these species-specific parasite inhibitors: Parabulins®.

Database

Knowledge

Assays

Expertise

Validation

Innovation

Optimization

Precision 2

Explore how Parabulins® are changing the game in parasitic disease control. Join us in shaping a healthier future.

CONTACT US